Cardiology therapeutic breakthroughs and ARNIs implementation in 2026
Revolutionizing neurohormonal blockade for long term stability The management of cardiac dysfunction has entered a new era with the widespread adoption of agents that target both the renin-angiotensin system and the natriuretic peptide system. In 2026, clinical observations confirmed that this dual-action approach is superior to older monotherapies in preventing the remodeling of heart tissue....
0 Commenti 0 condivisioni 13 Views 0 Anteprima
MTSocial https://mtsocial.ir